Beneficial Role of Bitter Melon Supplementation in Obesity and Related Complications in Metabolic Syndrome
Open accessThe DOI matches its Crossref record; 152 of the 153 references it cites were found in a registry or an index.
Abstract
Diabetes, obesity, and metabolic syndrome are becoming epidemic both in developed and developing countries in recent years. Complementary and alternative medicines have been used since ancient era for the treatment of diabetes and cardiovascular diseases. Bitter melon is widely used as vegetables in daily food in Bangladesh and several other countries in Asia. The fruits extract of bitter melon showed strong antioxidant and hypoglycemic activities in experimental condition both in vivo and in vitro. Recent scientific evaluation of this plant extracts also showed potential therapeutic benefit in diabetes and obesity related metabolic dysfunction in experimental animals and clinical studies. These beneficial effects are mediated probably by inducing lipid and fat metabolizing gene expression and increasing the function of AMPK and PPARs, and so forth. This review will thus focus on the recent findings on beneficial effect of Momordica charantia extracts on metabolic syndrome and discuss its potential mechanism of actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Additionally, its anti-inflammatory and antioxidant properties may alleviate obesity-related inflammation, potentially amplifying the pro-insulinotropic and β-cell protective effects of GLP-1 [204,324,325].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [204]
Experimental — accuracy not yet measuredIn the citing paper
“Another trial in T2DM patients showed that 3 months of cinnamon (1 g/day) decreased fasting and postprandial glucose, HbA1c, fasting insulin, insulin resistance, body weight, BMI, body fat (including visceral fat), and improved cholesterol profiles, with greater benefits in overweight individuals (BMI ≥ 27) [204].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [204]
In the citing paper
“Another trial in T2DM patients showed that 3 months of cinnamon (1 g/day) decreased fasting and postprandial glucose, HbA1c, fasting insulin, insulin resistance, body weight, BMI, body fat (including visceral fat), and improved cholesterol profiles, with greater benefits in overweight individuals (BMI ≥ 27) [204].”
From Nutritional Approaches to Enhance GLP-1 Analogue Therapy in Obesity: A Narrative Review (2025) · cites this paper as [204]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Furthermore, inflammatory cells such as macrophages infiltration are also increased in adipose tissues [12].”
BackgroundLagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., et al. (2006) · Cell · doi:10.1016/j.cell.2006.11.013 · Cited by 4,057
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050
Guh, D. P., Zhang, W., Bansback, N., Amarsi, Z., Birmingham, C. L., & Anis, A. H. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-88 · Cited by 3,855
Global burden of obesity in 2005 and projections to 2030
Kelly, T., Yang, W., Chen, C.-S., Reynolds, K., & He, J. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.102 · Cited by 3,319 · cited 1×
“It has been estimated that 58% of world population will become obese by 2030 [1].”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Subcutaneous and visceral adipose tissue: Structural and functional differences
Ibrahim, M. M. (2010) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00623.x · Cited by 2,238 · cited 4×
“ACC: Acetyl-CoA carboxylase ACE: Angiotensin-converting enzyme ALP: Alkaline phosphatase AST: Aspartate transaminase ALT: Alanine aminotransferase AMPK: 5 AMP-activated protein kinase (5 adenosine monophosphate-activated protein kinase) ApoB: Apolipoprotein B BAT: Brown adipose tissue BMI: Body mass index C/EBP: CEBPB…”
BackgroundInfluentialPuigserver, P., & Spiegelman, B. M. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0012 · Cited by 2,076
Research works printed but not linked: 7
- M. R. Khan and A. D. Omoloso, "Momordica charantia and Allium sativum: broad spectrum antibacterial activity, " Korean Journal of Pharmacognosy, vol. 29, no. 3, pp. 155-158, 1998.
- F. Bano, N. Akthar, and H. Naz, "Effect of the aqueous extracts of Momordica charantia on body weight of rats, " Journal of Basic and Applied Sciences, vol. 7, pp. 1-5, 2011.
- K. Zahra, M. A. Malik, M. S. Mughal, M. Arshad, and M. I. Sohail, "Hepatoprotective role of extracts of Momordica charantia L. in acetaminophen-induced toxicity in rabbits, " Journal of Animal and Plant Sciences, vol. 22, no. 2, pp. 273-277, 2012.
- R. H. H. Ching, L. O. Y. Yeung, I. M. Y. Tse, W.-H. Sit, and E. T. S. Li, "Supplementation of bitter melon to rats fed a high-fructose diet during gestation and lactation ameliorates fructose-induced dyslipidemia and hepatic oxidative stress in male offspring, " The Journal of Nutrition, vol. 141, no. 9, pp. 1664-1672, 2011. · DOI
- Y. Oishi, T. Sakamoto, H. Udagawa et al., "Inhibition of increases in blood glucose and serum neutral fat by Momordica charantia saponin fraction, " Bioscience, Biotechnology and Biochemistry, vol. 71, no. 3, pp. 735-740, 2007. · DOI
- C.-H. Tsai, E. C.-F. Chen, H.-S. Tsay, and C.-J. Huang, "Wild bitter gourd improves metabolic syndrome: a preliminary dietary supplementation trial, " Nutrition Journal, vol. 11, article 4, 2012. · DOI · Paper page
- R. Horax, N. Hettiarachchy, and P. Chen, "Extraction, quan- tification, and antioxidant activities of phenolics from pericarp and seeds of bitter melons (Momordica charantia) harvested at three maturity stages (immature, mature, and ripe), " Journal of Agricultural and Food Chemistry, vol. 58, no. 7, pp. 4428-4433, 2010. · DOI · Paper page
Cited by
Items 101–123 of 123
Houacine, C., Singh, J., Singh, R., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-615397/v1 · Cited by 1
Avaliação de uso de Momordica charantia L. no tratamento de asma em modelo animal
Ribeiro, A. C. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-06012017-101031
Rajamohan, S., Sridhar, R., Hemalatha, S., et al. (2018) · Annals of Phytomedicine An International Journal · doi:10.21276/ap.2018.7.1.19
Türkmen, A., Taghizadehghalehjoughi, A., Mohammadzadeh, M., et al. (2021) · Journal of Anatolian Environmental and Animal Sciences · doi:10.35229/jaes.835178
Phytochemical Profile and Antiobesity Potential ofMomordica charantiaLinn.
Karale, P. A., Dhawale, S. C., & Karale, M. A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.96808
“Bitter melon affects on various body organs to treat obesity and diabetes as [37]:”
BackgroundSugar-sweetened beverages induced metabolic syndrome and its reversal using bitter melon extract
Peraje, A. K. J., Puttaiah, A., Yadav, A. K., Prashant, A., & Vishwanath, P. (2021) · Asia-Pacific Journal of Molecular Biology and Biotechnology · doi:10.35118/apjmbb.2021.029.4.02 · Cited by 1
Vatsyayan, S., Raina, R., & Kumar, M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.6731
Talebi, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-07753-1_28
Tsabang, N. (2021) · Interventions in Obesity & Diabetes · doi:10.31031/iod.2021.05.000612
Between Medicines and Nutraceuticals in the Control of Diabetes Mellitus
Park, C., & Baek, Y. (2024) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v12i2.1371 · Cited by 1
“…of peripheral and skeletal muscle glucose utilization 20 , inhibition of intestinal glucose uptake 21 , inhibition of adipocyte differentiation 22 , suppression of key gluconeogenic enzymes 23 , stimulation of key enzyme of HMP pathway 24 , and preservation of islet β cells and their functions 25 .”
BackgroundSriniva, B., Padma, S. S. V., Naidu, L. N., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4236967/v1
Zulkifli, S. A., Gani, S. S. A., Zaidan, U. H., Misran, A. B., & Hassan, M. (2024) · Natural Product Research · doi:10.1080/14786419.2024.2344190 · Cited by 1
“…that β-sitosterol has a great anti-inflammatory effect due to the existence of an ethyl group on C-24 and the absence of a double bond on C-22. other than that, stigmasterol has been demonstrated to inhibit pro-inflammatory mediators, through the inhibition of the NF-k B pathway (Alam et al. 2015).”
A Compendium on Various Traditional Plants Used in the Management of Diabetes Mellitus
Mehla, S., Sharma, A., Mittal, V., & Sharma, D. (2024) · Current Drug Therapy · doi:10.2174/0115748855318662240909091130 · Cited by 1
Botanical and Nonbotanical Products for Glucose Lowering
(2021) · American Diabetes Association eBooks · doi:10.2337/9781580407687.ch01
Human Populations with Extreme Longevities
Pes, G. M., & Poulain, M. (2024) · Cambridge University Press eBooks · doi:10.1017/9781009007245.018 · Cited by 1
Nutraceutical and Nanonutraceutical Formulations for Obesity, Diabetes, and Kidney Disease
Sahu, S. (2025) · Springer eBooks · doi:10.1007/978-3-030-69677-1_6-1
Nageye, Q. A., Osman, W. A., Ahmed, H. M., et al. (2025) · Discover Food · doi:10.1007/s44187-025-00564-7
“Bitter gourd powder is mixed with 150 ml of water and administered to diabetic rats five times daily to lower fasting blood sugar levels [16].”
Lu, K., Chao, L., Wang, J., Wang, X.-Y., Cai, L.-J., Zhang, J.-J., & Zhang, S.-Q. (2025) · Scientific Reports · doi:10.1038/s41598-025-14977-y · Cited by 1
“It can be used to improve digestion, treat diabetes and obesity, and is well-known for its “plant insulin” activity 21–23 .”
Chavan, R. S., Khatib, N. A., Patil, V. S., & Dodakallanavar, J. (2025) · Pharmacological Research - Modern Chinese Medicine · doi:10.1016/j.prmcm.2025.100716 · Cited by 1
Nutraceutical and Nanonutraceutical Formulations for Obesity, Diabetes, and Kidney Disease
Sahu, S. (2026) · Springer eBooks · doi:10.1007/978-3-031-98791-5_6
Awwad, A. (2018) · theses.fr (ABES) · doi:10.70675/27dcfcbezb2a9z4c48zb673zf60decded54f · Cited by 1
Selection of bitter gourd (Momordica charantia L.) parental lines through line × tester analysis
Ahamed, F., Hasanuzzaman, M., & Kayess, M. O. (2026) · Discover Agriculture · doi:10.1007/s44279-026-00593-5
Weight management with functional foods: Natural solutions
Naeem, H., & Gul, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-34071-0.00023-3
Metadata
- Authors
- Alam, M. A., Uddin, R., Subhan, N., Rahman, M. M., Jain, P., & Reza, H. M.
- Affiliations
- North South University (BD)
- Stamford University Bangladesh (BD)
- Charles Sturt University (AU)
- Department of Pharmaceutical Sciences, North South University, Dhaka 1229, Bangladesh
- Corresponding author
- Alam, Md Ashraful
- Reza, Hasan Mahmud
- Venue
- Journal of Lipids
- Publisher
- Wiley
- Published
- 2015
- Volume
- 2015
- Pages
- 1-18
- ISSN
- 2090-3030 (ISSN-L)
- 2090-3049
- PMC
- PMC4306384
- OpenAlex
- W2002317151
- Semantic Scholar
- 7e58fcc6d7df4d25c8ba35d06f651567d26d5d5d
- Cited by
- 123
- References
- 153
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 10 · 2023: 7 · 2022: 13 · 2021: 24 · 2020: 10 · 2019: 12 · 2018: 15 · 2017: 9 · 2016: 5 · 2015: 2
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Lipids (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Advances in Cucurbitaceae Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- Momordica charantia, obesity, metabolic syndrome, diabetes mellitus, hypoglycemic activity, antioxidant activity, AMPK, peroxisome proliferator-activated receptors, lipid metabolism, fat metabolism, plant extracts, complementary and alternative medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.